Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Voting Common Stock, par value $0.0001 per share
-
Shares outstanding
-
52.4M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
9.86M
-
Shares change
-
-273K
-
Total reported value, excl. options
-
$44.4M
-
Value change
-
-$2.46M
-
Number of buys
-
11
-
Number of sells
-
-13
-
Price
-
$4.50
Significant Holders of TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) as of Q4 2021
35 filings reported holding TCRX - TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share as of Q4 2021.
TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.86M shares
of 52.4M outstanding shares and own 18.83% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.5M shares), BAKER BROS. ADVISORS LP (1.43M shares), HHLR ADVISORS, LTD. (1.28M shares), RA CAPITAL MANAGEMENT, L.P. (1.26M shares), Deer Management Co. LLC (1.25M shares), Alphabet Inc. (1.08M shares), DC Funds, LP (630K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (550K shares), VANGUARD GROUP INC (238K shares), and Tekla Capital Management LLC (200K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.